PUBLISHER: The Business Research Company | PRODUCT CODE: 1945552
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945552
Medical-grade liquid nitrogen is a highly purified cryogenic liquid produced under stringent industry standards to ensure its safety and effectiveness in medical environments. It is widely utilized in healthcare procedures such as cryotherapy for treating skin disorders, cryopreservation for storing biological specimens such as blood and reproductive cells, and as a cooling medium in surgical and research settings. Its manufacturing and distribution involve rigorous quality control measures, guaranteeing full traceability and adherence to regulatory standards to safeguard patient health.
The primary types of medical-grade liquid nitrogen are categorized by purity levels below 99%, between 99% and 99.9%, and above 99.9%. Liquid nitrogen with a purity below 99% is generated by liquefying nitrogen gas at extremely low temperatures and is suitable for specific medical uses such as cryotherapy and tissue preservation. These products are stored in various container formats including dewar flasks, pressurized cylinders, storage tanks, portable cryogenic containers, and bulk liquid nitrogen tanks. Distribution channels include direct sales, online platforms, medical supply distributors, retail pharmacies, and specialized medical suppliers. They are applied in areas such as cryopreservation, cryosurgery, medical laboratories, pharmaceutical processes, and dermatological treatments. End users include hospitals and clinics, biotechnology and pharmaceutical companies, research laboratories, and other healthcare facilities.
Tariffs are impacting the medical grade liquid nitrogen market by increasing costs of imported cryogenic equipment, storage vessels, transportation containers, and monitoring systems required for safe handling and distribution. Healthcare and research facilities in North America and Europe are most affected due to reliance on imported cryogenic infrastructure, while Asia-Pacific faces higher costs for specialized storage systems. These tariffs are raising operational and logistics expenses for suppliers. However, they are also encouraging domestic production of cryogenic equipment, localized gas processing facilities, and strengthened regional supply chains.
The medical grade liquid nitrogen market research report is one of a series of new reports from The Business Research Company that provides medical grade liquid nitrogen market statistics, including medical grade liquid nitrogen industry global market size, regional shares, competitors with a medical grade liquid nitrogen market share, detailed medical grade liquid nitrogen market segments, market trends and opportunities, and any further data you may need to thrive in the medical grade liquid nitrogen industry. This medical grade liquid nitrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical grade liquid nitrogen market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to expansion of medical research activities, increasing use of cryotherapy in dermatology, growth in biobanking applications, adoption of liquid nitrogen in pharmaceutical processes, rising demand from fertility clinics.
The medical grade liquid nitrogen market size is expected to see strong growth in the next few years. It will grow to $3.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of regenerative medicine applications, expansion of cell and gene therapy storage needs, rising demand for ultra-high purity nitrogen, growing investments in advanced cryogenic logistics, increasing healthcare infrastructure development. Major trends in the forecast period include increasing use of cryopreservation in healthcare, rising demand for high-purity medical gases, expansion of cold chain and cryogenic storage infrastructure, growing adoption of cryosurgical procedures, enhanced focus on regulatory compliance and traceability.
The growing demand for cryopreservation and cryosurgery in the medical sector is expected to drive the expansion of the medical-grade liquid nitrogen market. These applications involve using extremely low temperatures, primarily through liquid nitrogen, to preserve biological materials or to treat medical conditions by freezing and removing abnormal tissues. The increased use of cryopreservation and cryosurgery is linked to their role in fertility treatments and stem cell banking, with more individuals choosing to preserve reproductive and stem cells for future use due to medical conditions, personal choices, or advancements in regenerative medicine. Medical-grade liquid nitrogen supports these applications by offering a high-purity cryogenic solution essential for maintaining biological viability and enabling precise cryosurgical interventions. For example, in June 2024, Vitality Pro, a UK-based health and wellness company, reported that around 500 individuals globally have undergone cryonic preservation, with another 4,000 registered for future procedures, indicating growing interest in this emerging technology. Consequently, rising demand in cryopreservation and cryosurgery is fueling the growth of the medical-grade liquid nitrogen market.
Leading companies in the medical-grade liquid nitrogen market are introducing cutting-edge technologies such as liquid nitrogen cryotherapy devices to address chronic respiratory conditions through minimally invasive treatments. These devices utilize extremely cold liquid nitrogen to freeze and eliminate abnormal or damaged tissue, serving therapeutic purposes such as treating warts, precancerous lesions, and skin conditions. For instance, in July 2024, CSA Medical Inc., a US-based medical device manufacturer, completed patient enrollment in its SPRAY-CB trial for the RejuvenAir System, an innovative cryotherapy device. This system delivers targeted liquid nitrogen spray to treat chronic bronchitis by applying cold temperatures to damaged lung cells. The outpatient procedure promotes regenerative healing without causing scarring and represents a significant advancement in chronic obstructive pulmonary disease (COPD) treatment by addressing mucus overproduction and airway damage.
In January 2023, Linde plc, a UK/Ireland-based global industrial gases and engineering company, acquired nexAir, LLC for an undisclosed amount. Through this acquisition, Linde obtained full (100%) ownership of nexAir, consolidating its packaged gas distribution network in the United States and reinforcing its supply chain for gases, including medical-grade liquid nitrogen. nexAir, LLC is a U.S.-based independent packaged gas distributor serving industrial, healthcare, and welding customers.
Major companies operating in the medical grade liquid nitrogen market are Linde Gas & Equipment Inc., Air Liquide Healthcare, Air Products and Chemicals Inc., Airgas Inc., Nippon Sanso Holdings Corporation, Matheson Tri-Gas Inc., Gruppo SIAD, Gulf Cryo, AMCS Corporation, Red Ball Oxygen, MVS Engineering Pvt. Ltd., Coregas Pty Ltd., Kansal Industrial Gases, Stirling Cryogenics, CalOx Inc., US Gas, N-Two Medical Inc., Nitrogen Express, Cryogen (part of the Antares Alliance), Abhijit Enterprises
North America was the largest region in the medical grade liquid nitrogen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical grade liquid nitrogen market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical grade liquid nitrogen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical grade liquid nitrogen market consists of sales of products such as cryogenic storage tanks, liquid nitrogen dewars, delivery systems, and associated safety equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Grade Liquid Nitrogen Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical grade liquid nitrogen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical grade liquid nitrogen ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical grade liquid nitrogen market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.